Inogen (INGN) Net Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 1,842.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,842.00 |
| Dec 31, 2025 | -4,156.00 |
| Sep 30, 2025 | 329.00 |
| Jun 30, 2025 | -117.00 |
| Mar 31, 2025 | 1,018.00 |
| Dec 31, 2024 | 1,671.00 |
| Sep 30, 2024 | -2,175.00 |
| Jun 30, 2024 | -1,195.00 |
| Mar 31, 2024 | -1,773.00 |
| Dec 31, 2023 | -2,840.00 |
| Sep 30, 2023 | -5,216.00 |
| Jun 30, 2023 | -1,568.00 |
| Mar 31, 2023 | -2,629.00 |
| Dec 31, 2022 | 3,331.00 |
| Sep 30, 2022 | -1,650.00 |
| Jun 30, 2022 | -1,338.00 |
| Mar 31, 2022 | -2,356.00 |
| Dec 31, 2021 | -3,261.00 |
| Sep 30, 2021 | -221.00 |
| Jun 30, 2021 | -938.00 |
| Mar 31, 2021 | -1,456.00 |
| Dec 31, 2020 | -597.00 |
| Sep 30, 2020 | -1,292.00 |
| Jun 30, 2020 | -907.00 |
| Mar 31, 2020 | -1,321.00 |
| Dec 31, 2019 | -1,209.00 |
| Sep 30, 2019 | -216.00 |
| Jun 30, 2019 | -368.00 |
| Mar 31, 2019 | 1.00 |
| Dec 31, 2018 | 207.00 |
| Sep 30, 2018 | 1,063.00 |
| Jun 30, 2018 | 717.00 |
| Mar 31, 2018 | 895.00 |
| Dec 31, 2017 | -617.00 |
| Sep 30, 2017 | 337.00 |
| Jun 30, 2017 | 548.00 |
| Mar 31, 2017 | 1,172.00 |
| Dec 31, 2016 | -10,083.00 |
| Sep 30, 2016 | 1,509.00 |
| Jun 30, 2016 | 487.00 |
| Mar 31, 2016 | 123.00 |